December 6, 2022
COVID-19 remote patient monitoring study suggests improved outcomes, lower costs
By Advancing the Science contributor
By Jay Furst More than two years after it began, the COVID-19 pandemic continues to have a profound impact on how health care is delivered worldwide. Among the major changes in the U.S. is the pace at which telemedicine and virtual care has expanded. Mayo Clinic and other health care organizations rapidly adapted established remote […]
Tags: Center for Digital Health, Center for the Science of Health Care Delivery, cost of care, COVID-19, health care value, health disparities, Mayo Clinic Proceedings, remote patient monitoring, telehealth, telemedicine, Tufia Haddad
September 21, 2022
Maintaining quality care for patients with ALS — Lessons from the pandemic
By Advancing the Science contributor
By Susan Barber Lindquist The efficiency and effectiveness of telemedicine exploded during the COVID-19 pandemic. For patients with Lou Gehrig’s disease, also known as amyotrophic lateral sclerosis or ALS, telemedicine always has been an important piece of their medical care. A recent study in Neurology by Mayo Clinic researchers offers one more proof point. Tests […]
Tags: ALS, amyotrophic lateral sclerosis, clinical trials, COVID-19, Lou Gehrig's disease, Nathan Staff, neurology, remote patient monitoring, telehealth, telemedicine
January 14, 2022
Fueling the future of telehealth through expanded services, research in sports medicine
By Advancing the Science contributor
Mayo Clinic’s Center for Digital Health is finding new ways to provide care to patients with digital tools. At the same time, it is conducting innovative research to fuel practice transformation. From virtual rounds to emergency medicine video consults, Mayo Clinic has expanded the delivery of medical care through telehealth by more than 500% since […]
Tags: Center for Digital Health, concussion, emergency medicine, Neha Raukar, sports medicine, Steve Ommen, telehealth
June 14, 2021
Mayo Clinic Research in the news — 6/14/2021
By Advancing the Science contributor
Read on for news of the week that includes Mayo Clinic Research and research experts. Topics include a new Alzheimer’s medication, COVID-19, and various regenerative medicine innovations. US approves first new Alzheimer’s drug in 20 years BBC, 6/8/2021 A controversial drug to treat Alzheimer’s disease has been approved by the Food and Drug Administration in […]
Tags: aging, Alzheimer's disease, Andre Terzic, animal model, biomedical ethics, brain, BRCA1, breast cancer, cancer, Center for Regenerative Medicine, Cheryl Willman, concussion
June 7, 2021
Mayo Clinic Research in the news — 6/7/2021
By Advancing the Science contributor
Mayo Clinic research and faculty experts are cited by media outlets on a range of topics this week including the newly-approved Alzheimer’s drug (Monday, 6/7/2021), a new treatment for multiple myeloma and another for precocious puberty, as well as remote patient monitoring and other timely topics. Alzheimer’s Drug Poses a Dilemma for the F.D.A. The […]
Tags: Alzheimer's disease, autonomic nervous system, cardiovascular medicine, Chia-Chun Chiang, clinical informatics, clinical research, clinical trials, COVID-19, Cris Ross, David Knopman, DeLisa Fairweather, FDA
May 17, 2021
Mayo Clinic Research in the news — 5/17/2021
By Advancing the Science contributor
In the news this week, highlighting Mayo Clinic research and faculty experts, we welcome a new leader and see discussions across the research continuum. Topics range from quality improvement and innovation initiatives, to basic science discoveries, the latest in artificial intelligence in health care and clinical trials. All highlight investigations into improving outcomes and experience […]
Tags: Alzheimer's disease, asthma, biobank, blood clots, cardiology, Cheryl Willman, Chia-Chun Chiang, COVID-19, Dennis Dickson, dermatology, Filippo Pinto e Vairo, gene variant
March 8, 2021
Mayo Clinic Research in the news — 3/8/2021
By Advancing the Science contributor
In Mayo Clinic research news over the past seven days, the headlines covered medical marijuana, systemic racism, Alzheimer’s, and a range of other topics including COVID-19. Minnesota Senate bill could increase spinal cord research funding, KSTP, 3/4/2021 This $285 eye scan may someday detect Alzheimer’s risk. (It also requires plenty of curry flavoring.), Advisory Board, […]
Tags: ADHD, aging, Alzheimer's disease, biomarkers, cholesterol, clinical trials, colorectal cancer, COVID-19, dementia, health care systems engineering, health disparities, lymphoma